A previous study discovered that the “writers” of m6A methylation, METTL3 and METTL14, could play both oncogenic and tumor suppressor roles in numerous cancers [40, 41], while oncogenic roles have been reported for “erasers” such as FTO and ALKBH5 [7, 42, 43]. The gene discussed is METTL14; the disease is neoplasm.